ABEONA THERAPEUTICS INC.
For the period ended Mar 31, 2025. Filed May 15, 2025.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Mar 31, 2025 · Filed May 15, 2025
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 5. Other Information
Securities Trading Arrangements of Directors and Executive Officers
During the fiscal quarter ended March 31, 2025, Leila Alland, M.D., amember of the Company’s board of directors, adopted a “Rule 10b5-1 trading arrangement” as defined in Regulation S-K Item 408 providing for the sale from time to time of an aggregate of up to 64,800 shares of our common stock. The duration of the trading arrangement is until June 22, 2026, or earlier if all transactions under the trading arrangement are completed .
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.